Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

Researchers say more study is needed, but early results suggest the century-old vaccine could become a powerful new tool in ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

An HIV positive TB patient, holds a packet of tablets received as part of his treatment at Rutsanana Polyclinic in Glen Norah township, Harare June 24, 2019. - (Photo by Jekesai NJIKIZANA / AFP) ...

Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed ...

“If someone does not take proper treatment for tuberculosis, it can ultimately lead to the death to the patient,” warns ...

TODAY, various drugs are available that have proved very active against tubercle bacilli. It is known that the sooner they are resorted to, the more effective they will be. It is therefore more than ...

The Global TB Report 2025 released by the World Health Organization (WHO) highlights that India’s TB incidence has reduced ...